| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |